BP-704T is a novel drug delivery system developed by Biopharma Inc. that aims to improve targeted drug delivery and reduce side effects. The system uses biodegradable nanoparticles to encapsulate drug molecules and selectively release them at the site of a tumor or infection. Preliminary studies show BP-704T allows for higher concentrations of anti-cancer drugs to accumulate in tumor tissue with lower systemic exposure compared to traditional delivery methods.